INmune Bio
INMB
INMB
71 hedge funds and large institutions have $28.8M invested in INmune Bio in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+5
Holders Change %
+7.58%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
35
Reduced
6
Closed
8
Calls
$1.78M
Puts
$379K
Net Calls
+$1.4M
Net Calls Change
-$297K
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$636K |
| 2 |
2
Millennium Management
New York
|
$1.36M |
| 3 |
PHS
3
Pekin Hardy Strauss
Chicago,
Illinois
|
$389K |
| 4 |
4
Renaissance Technologies
New York
|
$868K |
| 5 |
5
Morgan Stanley
New York
|
$724K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Jane Street
New York
| – | -$79.4K | -14,725 | Closed |
|
|
OQS
77
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$72.7K | -13,482 | Closed |
|
|
VNA
78
Valley National Advisers
Bethlehem,
Pennsylvania
| – | -$5K | -1,000 | Closed |
|
|
NS
79
NBC Securities
Birmingham,
Alabama
| – | -$1K | -270 | Closed |
|